Skip to content

Facial Demodicosis and Ocular Demodicosis

Clinical Correlation Between Facial Demodicosis and Ocular Demodicosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04377841
Enrollment
120
Registered
2020-05-06
Start date
2020-04-13
Completion date
2020-12-14
Last updated
2020-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blepharitis, Demodex Infestation, Meibomian Gland Dysfunction, Pityriasis Folliculorum, Rosacea

Keywords

Demodex, Facial Demodicosis, Ocular Demodicosis, Direct Microscopic Examination, Rosacea, Blepharitis, Meibomian Gland Dysfunction, Pityriasis Folliculorum

Brief summary

To understand the association between facial demodicosis and ocular demodicosis, we plan to enroll patients with facial demodicosis, ocular demodicosis, or both, in order to analyze their clinical presentations, the density of Demodex infestation over facial skin and eyelashes, and possible risk factors of the two diagnoses.

Detailed description

Although facial demodicosis and ocular demodicosis are described in a variety of clinical presentations, the association between the two diagnoses is not clearly identified. Clinically, we plan to enroll 120 patients with facial demodicosis, ocular demodicosis. We will obtain their basic information, medical history, medication, and lifestyle. We will evaluate their clinical features. We will also perform quantitative tests including direct microscopic examination and cilia epilation test: 1. Direct microscopic examination: On glabella and bilateral cheeks, follicular contents in the 1-cm × 1-cm area will be squeezed out. The contents are transferred onto a glass slide, covered with mineral oil and a cover slide, and examined under the microscope. 2. Epilation: Four (4) non-adjacent cilia will be pulled from each upper eyelid and examined under the microscope. The total Demodex counts are recorded. We will analyze the clinical presentations, the density of Demodex infestation, and possible risk factors of the two diagnoses.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient with a diagnosis of facial demodicosis or ocular demodicosis. A. Facial demodicosis defined as both 1 and 2: 1. Clinical presentation of facial skin matches any of the followings: 1. Pityriasis folliculorum. 2. Papulopustular lesion. 3. Rosacea. 2. Demodex infestation detected by direct microscopic examination ≥ 5 mites/cm2. B. Ocular demodicosis defined as both 3 and 4: 3. Clinical presentation of ocular region matches any of the followings: 1. Chronic blepharitis. 2. Eyelash abnormalities: trichiasis, distichiasis, madarosis. 3. Meibomian gland dysfunction. 4. Recurrent chalazion. 5. Ocular rosacea. 4. Demodex infestation detected by cilia epilation test ≥ 1 mite/eyelid.

Exclusion criteria

1. Usage of oral Ivermectin, topical Ivermectin or topical tea tree oil in the past 1 month. 2. Patient who cannot tolerate direct microscopic examination or cilia epilation test.

Design outcomes

Primary

MeasureTime frameDescription
Quantitative tests of facial and ocular demodicosisOn initial evaluationAssociation between the results of direct microscopic examination and cilia epilation test

Secondary

MeasureTime frameDescription
Clinical features and quantitative tests of facial demodicosisOn initial evaluationAssociation between the clinical features and the result of direct microscopic examination
Clinical features and quantitative tests of ocular demodicosisOn initial evaluationAssociation between the clinical features and the result of cilia epilation

Countries

Taiwan

Contacts

Primary ContactChang-Ming Huang, M.D.
b98401078@ntu.edu.tw886-972652516

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026